Taiwan achieves WHO Gold Tier in historic hepatitis C elimination push
Taiwan has reached a major milestone in its fight against hepatitis C. The country has met the World Health Organization's Gold Tier targets for eliminating the virus. Officials have now submitted a formal report to the WHO for validation under its elimination framework. Hepatitis C remains a global health challenge, affecting around 58 million people worldwide. No vaccine exists, but direct-acting antiviral (DAA) treatments can cure the infection in 8 to 12 weeks. Taiwan has made these therapies widely accessible through its universal healthcare system, removing financial and structural barriers to care.
The country's efforts have focused on high-risk groups and those facing difficulties accessing treatment. As a result, 90.2% of people with chronic hepatitis C have been diagnosed, and 92.6% of those diagnosed have received treatment. Strict safety measures, including 100% screening of donated blood and safe injection practices, have further supported progress. These combined actions have led to a noticeable drop in liver cancer cases and deaths linked to hepatitis. Taiwan's success aligns with the WHO's 2030 goal to eliminate viral hepatitis as a public health threat.
Taiwan's submission of its Hepatitis C Elimination Report marks a key step toward WHO validation. The country's high screening and treatment rates, along with safer medical practices, have already reduced liver disease burdens. If approved, Taiwan will join a select group of nations recognised for reaching Gold Tier elimination targets.
Read also:
- India's Agriculture Minister Reviews Sector Progress Amid Heavy Rains, Crop Areas Up
- Cyprus, Kuwait Strengthen Strategic Partnership with Upcoming Ministerial Meeting
- Inspired & Paddy Power Extend Virtual Sports Partnership for UK & Ireland Retail
- South West & South East England: Check & Object to Lorry Operator Licensing Now
